Lyell Immunopharma

Biotechnology ResearchCalifornia, United States201-500 Employees

Lyell Immunopharma is a biotechnology company based in South San Francisco, California, focused on developing next-generation CAR T-cell therapies for cancer. The company describes its product candidates as enhanced with novel technology intended to generate T cells that resist exhaustion and possess durable stemness to drive durable tumor cytotoxicity and long-lasting clinical responses. Lyell positions itself as a late-stage clinical company with a pipeline of these therapies, founded by leaders in cell therapy whose decades of research advanced understanding of T-cell biology. It operates as an integrated organization capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. The company employs about 201 to 500 people and is located at 201 Haskins Way, South San Francisco, CA 94080, United States. More information is available on its website at https://lyell.com.

Sign up for free to view info

Email Format Employee directory